Diligence memo · auto-generated · as of July 2, 2026

InterRad Medical, Inc.

InterRad Medical, Inc. looks fair against its niche peers and is dormant on financing cadence.

DeprioritizeFinancing has gone silent well past the sector's normal cadence — treat as inactive until outside confirmation of a live operation.

Businessfiled

InterRad Medical, Inc. operates in Healthtech, based in PLYMOUTH.

No verified homepage on file yet — operating evidence is limited to the public record.

Capital & rounds (filed)filed

InterRad Medical, Inc. has raised $26M in disclosed capital across 7 recorded rounds, aggregated from public filings. Its latest round is modeled as Series A (a $4.0M–$15M round).

Largest single filing: $6.0M on 2014-07-01.

Most recent recorded round closed around 2019-02-15.

Valuation (modeled)modeled

Provath models InterRad Medical, Inc. at approximately $82M (range $4.7M–$448M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.

Read: Fair. Modeled value is 0.70× the median modeled value of Series A Healthtech companies in 2019–2021 (124 peers) — value vs value, same stage and era. Within the normal band (70% of peer median) for its niche.

Financing rhythm & timingmixed

Historic cadence: a new round about every 15 months.

Last raise 7.4 yr ago; this sector typically re-raises about every 14 months.

Silent for over 3× the sector's normal cadence.

The last round was 29.2× smaller than the prior — a bridge or down round.

Comparablesmixed

Capital scale ranks ahead of 84% of Healthtech peers (2138 compared).

Modeled value ranks above 72% of those peers.

Closest niche peers: Itamar Medical Ltd., ChartSpan Medical Technologies, Inc., 4G Clinical, LLC, Wellness Group Investors, LLC, Avation Medical, Inc..

Peoplefiled

22 named people on file across officers, directors and signatories.

Risks & flagsmixed

Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.

No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.